These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 9247523)

  • 61. Clinical safety profile of sotalol in the treatment of arrhythmias.
    MacNeil DJ; Davies RO; Deitchman D
    Am J Cardiol; 1993 Aug; 72(4):44A-50A. PubMed ID: 8346726
    [TBL] [Abstract][Full Text] [Related]  

  • 62. JTc prolongation with d,l-sotalol in women versus men.
    Lehmann MH; Hardy S; Archibald D; MacNeil DJ
    Am J Cardiol; 1999 Feb; 83(3):354-9. PubMed ID: 10072223
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Potential proarrhythmic effect of biventricular pacing: fact or myth?
    Shukla G; Chaudhry GM; Orlov M; Hoffmeister P; Haffajee C
    Heart Rhythm; 2005 Sep; 2(9):951-6. PubMed ID: 16171749
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Value of serial electropharmacological testing in managing patients resuscitated from cardiac arrest.
    Raviele A; Di Pede F; Delise P; Piccolo E
    Pacing Clin Electrophysiol; 1984 Sep; 7(5):850-60. PubMed ID: 6207498
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Contribution of delayed ventricular repolarization to the anti-arrhythmic efficacy of sotalol.
    Brachmann J; Senges J; Lengfelder W; Jauernig R; Rizos I; Czygan E; Cobbe SM; Kübler W
    Eur Heart J; 1985 Nov; 6 Suppl D():171-4. PubMed ID: 3936715
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia.
    Wichter T; Borggrefe M; Haverkamp W; Chen X; Breithardt G
    Circulation; 1992 Jul; 86(1):29-37. PubMed ID: 1617780
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Continuation of antiarrhythmic drugs, or arrhythmia surgery after multiple drug failures. A randomized trial in the treatment of postinfarction ventricular tachycardia.
    van Hemel NM; Kingma JH; Defauw JJ; Hoogteijling-van Dusseldorp E; Kelder JC; Beukema WP; Vermeulen FE
    Eur Heart J; 1996 Apr; 17(4):564-73. PubMed ID: 8733090
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Results of electrophysiological testing and long-term follow-up in patients sustaining cardiac arrest only while receiving type IA antiarrhythmic agents.
    Hook BG; Rosenthal ME; Marchlinski FE; Buxton AE; Josephson ME
    Pacing Clin Electrophysiol; 1992 Mar; 15(3):324-33. PubMed ID: 1372727
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
    Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
    Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term results of electrophysiologically guided sotalol therapy for life-threatening ventricular arrhythmias.
    Lee RJ; Wong M; Siu A; Namekawa-Wong M; Epstein LM; Fitzpatrick AP; Grogin HR; Scheinman MM; Lesh MD
    Am Heart J; 1996 Nov; 132(5):973-8. PubMed ID: 8892770
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Frequency-dependent electrophysiologic effects of d,l-sotalol and quinidine and modulation by beta-adrenergic stimulation.
    Sager PT; Behboodikhah M
    J Cardiovasc Electrophysiol; 1996 Feb; 7(2):102-12. PubMed ID: 8853020
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Idiopathic ventricular fibrillation: clinical, electrophysiologic characteristics and long-term outcomes.
    Tsai CF; Chen SA; Tai CT; Chiang CE; Ding YA; Chang MS
    Int J Cardiol; 1998 Mar; 64(1):47-55. PubMed ID: 9579816
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Programmed ventricular stimulation in survivors of acute myocardial infarction: long-term follow-up.
    Brembilla-Perrot B; de la Chaise AT; Briançon S; Suty-Selton C; Beurrier D; Martin N; Thiel B; Louis P; Danchin N
    Int J Cardiol; 1995 Mar; 49(1):55-65. PubMed ID: 7607767
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sustained torsade de pointes occurring early during oral sotalol therapy for atrial fibrillation recurrence prophylaxis in a patient without heart disease.
    D'Aloia A; Faggiano P; Brentana L; Boldini A; Pedrinazzi C; Procopio R; Dei Cas L
    Int J Cardiol; 2005 Dec; 105(3):337-9. PubMed ID: 15985302
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.
    Franz MR; Gray RA; Karasik P; Moore HJ; Singh SN
    Europace; 2014 Nov; 16 Suppl 4():iv39-iv45. PubMed ID: 25362169
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Zipes DP
    Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Long-term arrhythmic outcome in survivors of ventricular fibrillation with absence of inducible ventricular tachycardia.
    Zheutlin TA; Steinman RT; Mattioni TA; Kehoe RF
    Am J Cardiol; 1988 Dec; 62(17):1213-7. PubMed ID: 3195483
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
    Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.